Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mapping the Body's ICU journey: a new monitor could spot danger signs early

NCT ID NCT07773571

Knowledge-focused Sponsor: Shanghai Zhongshan Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This study aims to develop a research tool called the ICU Physiological State Space Monitor. Using data from 60,000 adult ICU patients, researchers will track daily changes across 10 body systems to see if they can identify patterns that precede sudden worsening. The goal is to see if this approach can predict events like the need for a breathing tube or kidney support within 72 hours, potentially offering a new way to understand and anticipate critical illness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a new tool that helps doctors spot ICU patients at risk of rapid decline earlier, potentially improving care and outcomes.
What could go wrong
This is a retrospective, single-center study, so results may not apply to other hospitals. The monitor is for research only, not real-time use, and may not improve patient outcomes in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients admitted to an ICU at Zhongshan Hospital, Fudan University between September 2021 and May 31, 2026 who have an extractable, uniquely identifiable ICU encounter in the ICCA reporting-layer database and meet the prespecified eligibility criteria. The study will use a fixed-time-window census of all eligible records. The principal participant count will be based on unique patients; ICU encounters and patient-days will form the analytic units for longitudinal modeling.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Admission to an ICU at Zhongshan Hospital, Fudan University between September 2021 and May 31, 2026, with a uniquely identifiable ICU encounter in the ICCA reporting-layer database. * ICU length of stay of at least 24 hours. * Availability of core variables from at least four physiological domains and at least one patient-day suitable for modeling. Exclusion Criteria: * Duplicate import of the same ICU encounter that cannot be reliably deduplicated. * Severe missingness, inconsistency, or irreconcilable error in key identifiers, ICU admission/discharge times, or core timestamps. * Test data, demonstration data, or records determined through data governance to be non-genuine patient records. * Inability to lock the primary source mapping for key variables, or overall data quality insufficient to support construction of the physiological state vector.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critical illness

Contacts and locations

Locations

  • Zhongshan Hospital

    Shanghai, Shanghai Municipality, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.